Biotechnology Stocks

1. Complete Genomics, Inc. (GNOM): Biotechnology Industry. Market cap of $498.22M. Current price at $15.37 vs. target price $18.38 (implies a potential upside of 19.58%). Net insider purchases over the past 6 months at 1.65M representing 21.29% of the company's 7.75M share float.

2. QLT Inc. (QLTI): Biotechnology Industry. Market cap of $352.78M. Current price at $6.78 vs. target price $10 (implies a potential upside of 47.49%). Net insider purchases over the past 6 months at 258,318, representing 0.79% of the company's 32.58M share float. It's been a rough couple of days for the stock, losing 8.07% over the last week.

3. Regeneron Pharmaceuticals, Inc. (REGN): Biotechnology Industry. Market cap of $5.16B. Current price at $56.72 vs. target price $65.45 (implies a potential upside of 15.39%). Net insider purchases over the past 6 months at 675,375, representing 0.96% of the company's 70.34M share float. The stock has gained 113.63% over the last year.

4. Theravance Inc. (THRX): Biotechnology Industry. Market cap of $1.91B. Current price at $21.29 vs. target price $27.8 (implies a potential upside of 30.58%). Net insider purchases over the past 6 months at 5.19M, representing 9.92% of the company's 52.32M share float. The stock is a short squeeze candidate, with a short float at 8.61% (equivalent to 14.49 days of average volume). The stock has performed poorly over the last month, losing 10.57%.

5. ZIOPHARM Oncology, Inc. (ZIOP): Biotechnology Industry. Market cap of $398.04M. Current price at $5.97 vs. target price $9.17 (implies a potential upside of 53.6%). Net insider purchases over the past 6 months at 433,240, representing 8.21% of the company's 52.80M share float. The stock is a short squeeze candidate, with a short float at 10.21% (equivalent to 8.5 days of average volume). The stock has performed poorly over the last month, losing 11.24%.

http://seekingalpha.com/article/275520-5-biotech-stocks-with-insider-buying-and-undervalued-by-analysts-eps